|
Market Closed -
Nasdaq
21:00:00 19/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.7780 USD | +5.61% |
|
+11.11% | -29.91% |
| Market Cap | 21.32M 18.29M 17.08M 15.67M 29.47M 2.04B 29.95M 202M 78.92M 1.02B 80.07M 78.33M 3.38B | P/E 2024 |
-0.79x | P/E 2025 | -0.31x |
|---|---|---|---|---|---|
| Enterprise Value | 89.86M 77.08M 71.98M 66.04M 124M 8.59B 126M 849M 333M 4.31B 337M 330M 14.24B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 3.77x |
| Free-Float |
62.82% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.61% | ||
| 1 week | +11.11% | ||
| Current month | +22.46% | ||
| 1 month | -0.29% | ||
| 3 months | -2.56% | ||
| 6 months | -47.43% | ||
| Current year | -29.91% |
| 1 week | 0.68 |  | 0.85 |
| 1 month | 0.6 | | 0.85 |
| Current year | 0.56 | | 1.51 |
| 1 year | 0.56 | | 4.01 |
| 3 years | 0.56 | | 7.97 |
| 5 years | 0.56 | | 131.86 |
| 10 years | 0.56 | | 134 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 31/12/2015 | |
John Sprague
DFI | Director of Finance/CFO | 67 | 26/02/2026 |
Anna Gosiewska
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 31/12/2015 | |
Peter Diamandis
BRD | Director/Board Member | 64 | 30/06/2017 |
Diane Parks
BRD | Director/Board Member | 73 | 02/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/01/26 | Free | Director | 19,231 | 0.0667% | ||
| 12/01/26 | Free | Director | 30,000 | 0.1040% | ||
| 12/01/26 | Free | Director | 19,231 | 0.0667% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.61% | +11.11% | -81.25% | -75.61% | 21.32M | |
| +3.78% | +5.50% | +46.51% | +3.50% | 80.91B | |
| +5.49% | +20.35% | -38.64% | -38.47% | 53.62B | |
| +0.85% | -4.04% | -2.31% | +30.25% | 50.13B | |
| +0.23% | -3.71% | +11.44% | +170.56% | 47.97B | |
| +4.24% | +8.67% | +63.02% | -15.16% | 31.41B | |
| +176.97% | +187.90% | +520.79% | +71.60% | 25.14B | |
| +4.05% | +6.11% | +51.28% | +100.61% | 25.03B | |
| +1.66% | +2.83% | -3.58% | +212.40% | 21.45B | |
| +0.22% | +5.48% | +65.69% | +127.79% | 16.93B | |
| Average | +20.03% | +4.03% | +63.29% | +58.75% | 35.26B | |
| Weighted average by Cap. | +14.83% | +4.13% | +55.33% | +52.40% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 54.22M 46.51M 43.43M 39.85M 74.93M 5.18B 76.16M 512M 201M 2.6B 204M 199M 8.59B | 26.55M 22.77M 21.27M 19.51M 36.69M 2.54B 37.29M 251M 98.26M 1.27B 99.69M 97.52M 4.21B |
| Net income | -57.89M -49.66M -46.37M -42.54M -80M -5.53B -81.32M -547M -214M -2.78B -217M -213M -9.18B | -91.72M -78.67M -73.46M -67.4M -127M -8.77B -129M -867M -339M -4.4B -344M -337M -14.54B |
| Net Debt | 68.1M 58.41M 54.55M 50.04M 94.11M 6.51B 95.66M 644M 252M 3.26B 256M 250M 10.79B | 68.54M 58.79M 54.9M 50.37M 94.72M 6.55B 96.28M 648M 254M 3.29B 257M 252M 10.86B |
Employees
115
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/08/26 | US$0.7780 | +5.61% | 48,753 |
| 18/08/26 | US$0.7367 | +5.85% | 72,811 |
| 17/08/26 | US$0.6960 | +0.03% | 17,585 |
| 14/08/26 | US$0.6958 | +0.07% | 11,415 |
| 13/08/26 | US$0.6953 | +0.77% | 7,070 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CELU Stock
Select your edition
All financial news and data tailored to specific country editions
